Abstract:Vacuolar-type H+-ATPases (V-ATPases) are macromolecular proton pumps that acidify intracellular cargos and deliver protons across the plasma membrane of a variety of specialized cells, including bone-resorbing osteoclasts. Extracellular acidification is crucial for osteoclastic bone resorption, a process that initiates the dissolution of mineralized bone matrix. While the importance of V-ATPases in osteoclastic resorptive function is well-defined, whether V-ATPases facilitate additional aspects of osteoclast function and/or formation remains largely obscure. Here we report that the V-ATPase accessory subunit Ac45 participates in both osteoclast formation and function. Using a siRNA-based approach, we show that targeted suppression of Ac45 impairs intracellular acidification and endocytosis, both are prerequisite for osteoclastic bone resorptive function in vitro. Interestingly, we find that knockdown of Ac45 also attenuates osteoclastogenesis owing to a reduced fusion capacity of osteoclastic precursor cells. Finally, in an effort to gain more detailed insights into the functional role of Ac45 in osteoclasts, we attempted to generate osteoclast-specific Ac45 conditional knockout mice using a Cathepsin K-Cre-LoxP system. Surprisingly, however, insertion of the neomycin cassette in the Ac45-FloxNeo mice resulted in marked disturbances in CNS development and ensuing embryonic lethality thus precluding functional assessment of Ac45 in osteoclasts and peripheral bone tissues. Based on these unexpected findings we propose that, in addition to its canonical function in V-ATPase-mediated acidification, Ac45 plays versatile roles during osteoclast formation and function.

V-ATPases and Osteoclasts: Ambiguous Future of V-ATPases Inhibitors in Osteoporosis

The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis

V-ATPases in Osteoclasts: Structure, Function and Potential Inhibitors of Bone Resorption

Research and Application of Target Therapy for Osteoporosis

Deficiency of ATP6V1H Causes Bone Loss by Inhibiting Bone Resorption and Bone Formation Through the TGF-β1 Pathway

v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation

Modulation of the Vitamin D/vitamin D Receptor System in Osteoporosis Pathogenesis: Insights and Therapeutic Approaches

Vacuolar H+‐ATPase in Diabetes, Hypertension, and Atherosclerosis

Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review

Versatile Roles of V-ATPases Accessory Subunit Ac45 in Osteoclast Formation and Function

Cancer-ATPases as a New Strategy against + Targeting Vacuolar H Updated

Long Noncoding RNA Lnc-Tcea1-3 Affects Osteoclastic Function by Regulating ATP6V1H.

Targeting vacuolar H+-ATPases as a new strategy against cancer.

ATP-induced cell death: a novel hypothesis for osteoporosis

The different functions of V-ATPase subunits in adipocyte differentiation and their expression in obese mice

Emerging Therapeutic Targets for Osteoporosis Treatment.

Exploring the impact of osteoprotegerin on osteoclast and precursor fusion: Mechanisms and modulation by ATP

V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities

Tumor necrosis factor alpha enhances the bone-resorptive capabilities of osteoclasts by improving the expression and activity of vocuolar-type ATPase

Atp6v1h Deficiency Impairs Bone Development Through Activation of Mmp9 and Mmp13

The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics